140
Table 9.1(continued)Traverse et al. [^31,^32]9512BMMNC150 × 106ICAMIMRITraverse et al. [75]876BMMNC1.47 ± 17 × 108ICAMIMRITraverse et al. [76]406BMMNC1 × 108ICAMIMRITse et al. [77]286BMMNC1.67 ± 0.34 × 107 (low),4.20 ± 2.80 × 107 (High)IMCIHDMRITuran et al. [78]5612BMMNC99 ± 25 × 106ICCIHDLV GTuran et al. [79]6212BMMNC9.6 ± 3.2 × 107ICAMILV GWohrle et al. [80,^81]4036BMMNC381 ± 130 × 106ICAMIMRIYao et al. [82]476BMMNC180 × 106ICCIHDMRIYao et al. [83]3912BMMNC1.9 ± 1.2 × 108 (singletransfusion), 2.0 ± 1.4 × 108(repeat transfusion)ICAMIMRIZhao et al. [84]366BMMNC6.59 ± 5.12 × 108IM w/CABGCIHDEchoModified and reproduced from Afzal et al.Circ Res2015;117:558–575 with permissionAMIacute myocardial infarction,BMCbone marrow cells,BMMNCbone marrow mononuclear cells,CABGcoronary artery bypass graft,CIHDchronicischemic heart disease,Echoechocardiography,EFejection fraction,Endomyo endomyocardial,ICintracoronary,IMintramuscular,ISinfarct size,LVGleftventriculography,MImyocardial infarction,MRImagnetic resonance imaging,MSCmesenchymal stem cells,NAnot available,NRnot reported,PETpositronemission tomography,Transmyotransmyocardial,RCTrandomized controlled trial,RNVradionuclide ventriculography,SPECTsingle-photon emission comSource puted tomographySample sizeMean follow-up duration (months)Cell typeNo. of cells transplantedRoute of injectionType of IHDImaging modalitiesA. Samanta et al.